Journal of Cancer Therapy

Vol.10 No.1(2019), Paper ID 90127, 17 pages

DOI:10.4236/jct.2019.101006

 

Investigation of Methylation Profiles of TP53, Caspase 9, Caspase 8, Caspase 3 Genes Treated with DNA Methyl Transferase Inhibitor (DNMTi) Zebularine (ZEB) and Caffeic Acid Phenethyl Ester (CAPE) on MCF-7 and MDA-MB-231 Breast Cancer Cell Lines

 

Onur Eroglu, Esin Guvenir Celik, Hacer Kaya, Merve Celen, Mustafa Karabicici, Elif Karacoban

 

Biotechnology Research and Application Center, Bilecik Seyh Edebali University, Bilecik, Turkey
Department of Molecular Biology and Genetics, Faculty of Science and Letters, Bilecik Seyh Edebali University, Bilecik, Turkey
Department of Molecular Biology and Genetics, Faculty of Science and Letters, Bilecik Seyh Edebali University, Bilecik, Turkey
Vocational School of Medical Services, Program of Medical Laboratory Techniques, Bilecik Seyh Edebali University, Bilecik, Turkey
Izmir Biomedicine and Genome Center, Dokuz Eylul University, Izmir, Turkey
Department of Molecular Biology and Genetics, Faculty of Science and Letters, Bilecik Seyh Edebali University, Bilecik, Turkey

 

Copyright © 2019 Onur Eroglu, Esin Guvenir Celik, Hacer Kaya, Merve Celen, Mustafa Karabicici, Elif Karacoban et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Eroglu, O. , Celik, E. , Kaya, H. , Celen, M. , Karabicici, M. and Karacoban, E. (2019) Investigation of Methylation Profiles of TP53, Caspase 9, Caspase 8, Caspase 3 Genes Treated with DNA Methyl Transferase Inhibitor (DNMTi) Zebularine (ZEB) and Caffeic Acid Phenethyl Ester (CAPE) on MCF-7 and MDA-MB-231 Breast Cancer Cell Lines. Journal of Cancer Therapy, 10, 69-85. doi: 10.4236/jct.2019.101006.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.